Welcome to the STAMPEDE website. We will be adding regular
updates about the trial and have made all of the
trial documentation available for you to download. Please
check the site regularly and add us to your favourites!
Prostate cancer accounts for around one fifth of all male
cancers. In the UK there are around 25,000 new cases each year and
around 10,000 deaths. Most men with prostate cancer are given
hormone therapy and this is often effective for a short time at
stopping the tumour growing. However in most cases over time the
tumour will start to grow again.
The aim of this trial is to try to prevent the tumour re-growth
by adding other treatment to the hormone therapy. The trial is
currently assessing abiraterone and enzalutamide in combination
with hormone therapy or radiotherapy (newly diagnosed metastatic
patients only) in combination with hormone therapy.